Redirecting to https://www.wfmz.com/news/pr_newswire/pr_newswire_health/dizal-announces-positive-topline-phase-3-results-from-wu-kong28-study-evaluating-oral-once-daily/article_f8c67045-53f1-531b-9978-88e5360f73b3.html